Substituted amino ketone compounds
OwnerHans-Ulrich Demuth, Ulrich Heiser +2inventors
InventorsHans-Ulrich Demuth, Ulrich Heiser, Torsten Hoffmann, Andre Niestroj
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds of the general formula I B—(CH—R1)n—C(═X2)—D (I) and pharmaceutically acceptable salts thereof including stereoisomers, to the use of the compounds for the treatment of impaired glucose tolerance, glucosuria, hyperlipidaemia, metabolic acidosis, diabetes mellitus, diabetic neuropathy and nephropathy and of sequelae caused by diabetes mellitus in mammals.
Claims22
compounds of the general formula I
- B—(CH—R1)n—C(=X2)—D (I)
- wherein
- n is 0 or 1,
- R1 stands for H, C1-C9 branched or straight chain alkyl, n-butan-2-yl, n-prop-2-yl or isobutyl, C2-C9 branched or straight chain alkenyl, C3-C8 cycloalkyl, C5-C7 cycloalkenyl, aryl, heteroaryl or a side chain of a natural amino acid or derivatives thereof,
- X2 stands for O,NR6, N+(R7)2, or S,
- B is selected from the following groups:
- 23
- where X5 is H or an acyl or oxycarbonyl group including amino acids,
- R5 is H, C1-C9 branched or straight chain alkyl, C2-C9 branched or straight chain alkenyl, C3-C8 cycloalkyl, C5-C7 cycloalkenyl, aryl, heteroaryl or a side chain of a natural amino acid or mimetics thereof, or a group of the formula —(CH)m—NH—C5H3N—Y where m is an integer of 2-4, —C5H3N—Y is a divalent pyridyl moiety and Y is a hydrogen atom, a halogen atom, a nitro group or a cyano group,
- Z is selected from H, pyridyl or optionally substituted phenyl, optionally substituted alkyl groups, alkoxy groups, halogens, nitro, cyano and carboxy groups,
- W is selected from H, pyridyl or optionally substituted phenyl, optionally substituted alkyl groups, alkoxy groups, halogens, nitro, cyano and carboxy groups,
- W1 is H or optionally substituted alkyl, alkoxy or optionally substituted phenyl, and
- Z1 is H, or optionally substituted alkyl,
- R3 and R4 are independently H, hydroxy, alkyl, alkoxy, aralkoxy, nitro, cyano or halogen,
- D is an optionally substituted compound of the formula
- 24
- which can be saturated, or can have one, two or three double bonds, wherein
- X8 to X11 are independently CH, N. N+(R7), or CR8, if unsaturated, or
- X8 to X11 are independently CH2, NH, NH+(R7), O. or S if saturated,
- X12 is CHA, NA, CH2, NH, NH+(R7), or CHR8, if saturated or
- X12is CA, NA+, CH, N, N+(R7), or CR8, if unsaturated and
- A is H or an isoster of a carboxylic acid, PO3R5R6, a tetrazole, an amide, an ester or an acid anhydride,
- R6, R7 R8 and R9 are independently selected from H, optionally substituted C1-C9 branched or straight chain alkyl, or optionally substituted C2-C9 branched or straight chain alkenyl, or optionally substituted C3-C8 cycloalkyl, or an optionally substituted C5-C7 cycloalkenyl, or an optionally substituted aryl residue.
Compounds according to any one of the preceding claims, wherein B has the following formula:
- 31
- wherein the residues are as defined above.
A pharmaceutical composition for parenteral, enteral or oral administration, characterised in that it contains at least one compound according to any one of the preceding claims optionally in combination with customary carriers and/or excipients.
Use of compounds or pharmaceutical compositions according to any one of the preceding claims for the preparation of a medicament for the in vivo inhibition of DP IV and/or DP IV-like enzymes.
Dependencies are inferred from the claim text.